Literature DB >> 29381428

Impact of Multiple Single-Nucleotide Polymorphisms Within mprF on Daptomycin Resistance in Staphylococcus aureus.

Soo-Jin Yang1, Nagendra N Mishra2,3, Kyoung-Mi Kang1, Gi-Yong Lee1, Jong-Hwan Park4, Arnold S Bayer2,3.   

Abstract

A number of single nucleotide polymorphisms (SNPs) within the mprF open reading frame (ORF) have been associated with daptomycin-resistance (DAP-R) in Staphylococcus aureus. Such SNPs have been found throughout the mprF ORF, although there are clearly preferred "hot spots" within this gene frequently linked to DAP-R phenotype. These mprF SNPs are often correlated with a gain-in-function phenotype, either in terms of increased production (synthase activity) and/or enhanced translocation (translocase activity) of lysyl-phosphatidylglycerol (L-PG) within its cell membrane. However, it is unclear if multiple hot spot mprF SNPs can accumulate within mprF ORFs and cause additive elevations of DAP minimum inhibitory concentrations (MICs). In this study, we used a previously well-characterized plasmid complementation system in S. aureus Newman ΔmprF mutant to express: (1) single point-mutated forms of mprF ORFs cloned from two DAP-R S. aureus strains (mprFS295L or mprFT345A) and (2) dual point-mutated forms of mprF ORFs simultaneously harboring SNPs in the central bifunctional domain and synthase domain in MprF, respectively (mprFS295L+L826F or mprFT345A+L826F). The current study revealed that, although individual hot spot point mutations within mprF ORF can recapitulate signature DAP-R-associated phenotypes (i.e., increased DAP MICs, enhanced surface positive charge, and increased L-PG synthesis), accumulation of such hot spot point mutations paradoxically caused reduction in these latter three metrics.

Entities:  

Keywords:  Staphylococcus aureus; antimicrobial peptides; daptomycin; mprF

Mesh:

Substances:

Year:  2018        PMID: 29381428      PMCID: PMC6200021          DOI: 10.1089/mdr.2017.0156

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  36 in total

Review 1.  Mechanisms of drug resistance: daptomycin resistance.

Authors:  Truc T Tran; Jose M Munita; Cesar A Arias
Journal:  Ann N Y Acad Sci       Date:  2015-10-23       Impact factor: 5.691

2.  In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.

Authors:  Nagendra N Mishra; James McKinnell; Michael R Yeaman; Aileen Rubio; Cynthia C Nast; Liang Chen; Barry N Kreiswirth; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

3.  Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus.

Authors:  Hiromi Nishi; Hitoshi Komatsuzawa; Tamaki Fujiwara; Nadine McCallum; Motoyuki Sugai
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action.

Authors:  M R Yeaman; A S Bayer; S P Koo; W Foss; P M Sullam
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

5.  Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains.

Authors:  Soo-Jin Yang; Yan Q Xiong; Paul M Dunman; Jacques Schrenzel; Patrice François; Andreas Peschel; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

6.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

7.  Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.

Authors:  Arnold S Bayer; Nagendra N Mishra; George Sakoulas; Poochit Nonejuie; Cynthia C Nast; Joseph Pogliano; Kuan-Tsen Chen; Steven N Ellison; Michael R Yeaman; Soo-Jin Yang
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

8.  Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.

Authors:  Nagendra N Mishra; Soo-Jin Yang; Ayumi Sawa; Aileen Rubio; Cynthia C Nast; Michael R Yeaman; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

9.  The lipid-modifying multiple peptide resistance factor is an oligomer consisting of distinct interacting synthase and flippase subunits.

Authors:  Christoph M Ernst; Sebastian Kuhn; Christoph J Slavetinsky; Bernhard Krismer; Simon Heilbronner; Cordula Gekeler; Dirk Kraus; Samuel Wagner; Andreas Peschel
Journal:  MBio       Date:  2015-01-27       Impact factor: 7.867

10.  The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion.

Authors:  Christoph M Ernst; Petra Staubitz; Nagendra N Mishra; Soo-Jin Yang; Gabriele Hornig; Hubert Kalbacher; Arnold S Bayer; Dirk Kraus; Andreas Peschel
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

View more
  8 in total

1.  Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.

Authors:  Rachel E Jenson; Sarah L Baines; Benjamin P Howden; Nagendra N Mishra; Sabrina Farah; Cassandra Lew; Andrew D Berti; Sanjay K Shukla; Arnold S Bayer; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

2.  Phenotypic and genetic changes associated with the seesaw effect in MRSA strain N315 in a bioreactor model.

Authors:  Smruti Mishra; Erica Lasek-Nesselquist; Anarv Mathur; Zhuo Ma; Kanpong Boonthaworn; Nicholas O'Donnell; Haixin Sui; Janice D Pata; Kathleen A McDonough; Pradeepa Jayachandran; Meenakshi Malik
Journal:  J Glob Antimicrob Resist       Date:  2022-01-24       Impact factor: 4.349

3.  Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain.

Authors:  Feng-Jui Chen; Tsai-Ling Lauderdale; Chen-Hsiang Lee; Yu-Chieh Hsu; I-Wen Huang; Pei-Chi Hsu; Chung-Shi Yang
Journal:  Front Microbiol       Date:  2018-05-25       Impact factor: 5.640

4.  Genetic Factors Associated with Increased Host Defense Antimicrobial Peptide Resistance in Sequence Type 5 Healthcare-Associated MRSA Clinical Isolates.

Authors:  Kyoung-Mi Kang; Gi Yong Lee; Soo-Jin Yang
Journal:  Biomolecules       Date:  2020-10-07

5.  Genome-Wide Association Studies for the Detection of Genetic Variants Associated With Daptomycin and Ceftaroline Resistance in Staphylococcus aureus.

Authors:  Robert E Weber; Stephan Fuchs; Franziska Layer; Anna Sommer; Jennifer K Bender; Andrea Thürmer; Guido Werner; Birgit Strommenger
Journal:  Front Microbiol       Date:  2021-02-15       Impact factor: 5.640

6.  Cell Membrane Adaptations Mediate β-Lactam-Induced Resensitization of Daptomycin-Resistant (DAP-R) Staphylococcus aureus In Vitro.

Authors:  Nagendra N Mishra; Arnold S Bayer; Sarah L Baines; Ashleigh S Hayes; Benjamin P Howden; Christian K Lapitan; Cassandra Lew; Warren E Rose
Journal:  Microorganisms       Date:  2021-05-11

7.  β-Lactam-Induced Cell Envelope Adaptations, Not Solely Enhanced Daptomycin Binding, Underlie Daptomycin-β-Lactam Synergy in Methicillin-Resistant Staphylococcus aureus.

Authors:  Cassandra Lew; Nagendra N Mishra; Arnold S Bayer; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

8.  Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Kanate Thitiananpakorn; Yoshifumi Aiba; Xin-Ee Tan; Shinya Watanabe; Kotaro Kiga; Yusuke Sato'o; Tanit Boonsiri; Feng-Yu Li; Teppei Sasahara; Yusuke Taki; Aa Haeruman Azam; Yuancheng Zhang; Longzhu Cui
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.